Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Middle East News Journal.
Press releases published on July 30, 2025
NeuroStar Announces New Publication in JAACAP Open Highlighting Treatment Efficacy in Depressed Adolescents
GlobeNewswire
·
July 30, 2025
MALVERN, Pa., July 30, 2025 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who suffer from neurohealth disorders, …
Tenaya Receives Positive Safety Reviews from Independent DSMBs to Advance Both TN-201 and TN-401 Gene Therapy Clinical Trials as Designed
GlobeNewswire
·
July 30, 2025
Enrollment in Both Dose Cohorts of the MyPEAK™-1 Phase 1b/2 Clinical Trial of TN-201 for Hypertrophic Cardiomyopathy (HCM) Complete; Follow-up Data from Cohort 1 and Initial Data from Cohort 2 Expected in Fourth Quarter of 2025 First Patient Dosed in 6E13 …
Protagenic Therapeutics Announces Grant of new patent in Japan for its Modified Stilbenoid Program Drug Candidates
GlobeNewswire
·
July 30, 2025
NEW YORK and SANTA BARBARA, Calif., July 30, 2025 (GLOBE NEWSWIRE) -- Protagenic Therapeutics, Inc. (Nasdaq: PTIX) (the “Company”) today announces that on July 18, 2025, the Japanese Patent Office granted Patent JP 7714571B, a patent which runs until March …
Clearmind Medicine Files International Patent Application for Novel Combination Therapy Targeting Weight Loss and Fatty Liver Disease
GlobeNewswire
·
July 30, 2025
Vancouver, Canada, July 30, 2025 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) (“Clearmind” or the "Company"), a clinical-stage biotech company focused on discovery and development of novel psychedelic-derived therapeutics to …
SoftBank Vision Fund 2 Makes Strategic Investment in Classiq, Expanding Series C
GlobeNewswire
·
July 30, 2025
A Media Snippet accompanying this announcement is available by clicking on this link. TEL AVIV, Israel, July 30, 2025 (GLOBE NEWSWIRE) -- Classiq, the leader in quantum software development platforms, today announced an investment by SoftBank Vision Fund 2 …
BrainsWay to Report Second Quarter 2025 Financial Results on August 13, 2025
GlobeNewswire
·
July 30, 2025
BURLINGTON, Mass. and JERUSALEM, July 30, 2025 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ …
PolyPid to Report Second Quarter 2025 Financial Results and Operational Highlights on August 13, 2025
GlobeNewswire
·
July 30, 2025
PETACH TIKVA, Israel, July 30, 2025 (GLOBE NEWSWIRE) -- PolyPid Ltd. (Nasdaq: PYPD) ("PolyPid" or the "Company"), a late-stage biopharma company aiming to improve surgical outcomes, today announced that it will report its second quarter 2025 financial …
Maxus Mining Expands Land Holdings at the Quarry Antimony Project in British Columbia, Canada
GlobeNewswire
·
July 30, 2025
VANCOUVER, British Columbia, July 30, 2025 (GLOBE NEWSWIRE) -- Maxus Mining Inc. (“Maxus” or the “Company”) (CSE: MAXM | FRA: R7V), is pleased to announce that the Company has expanded its land holdings through strategic staking of an additional 1,803 …
Skyharbour Expands Uranium Exploration Portfolio to Over 616,000 Hectares Across Thirty-Seven Projects in the Athabasca Basin, Northern Saskatchewan
GlobeNewswire
·
July 30, 2025
Vancouver, BC, July 30, 2025 (GLOBE NEWSWIRE) -- Skyharbour Resources Ltd. (TSX-V: SYH) (OTCQX: SYHBF) (Frankfurt: SC1P) (“Skyharbour” or the “Company”), is pleased to announce that it has acquired, through inexpensive online staking, 21 new prospective …
Aventis Energy Announces Management Changes
GlobeNewswire
·
July 30, 2025
VANCOUVER, British Columbia, July 30, 2025 (GLOBE NEWSWIRE) -- Aventis Energy (“Aventis” or the “Company”) (CSE:AVE | FRA:C0O0 | OTC: VBAMF) is pleased to announce the appointment of Michael Mulberry, current Director of Aventis, as Chief Executive Officer …
Nautilus Biotechnology Announces Agreement with the Allen Institute, Further Validating its Approach to Single-Molecule Proteomics
GlobeNewswire
·
July 30, 2025
• Allen Institute to employ Iterative Mapping, Nautilus’ single-molecule proteomics method, to investigate connection between tau protein and Alzheimer’s disease • Agreement links the organizations’ next-generation proteomics technology and neuroscience …
ORYZON Reports Financial Results and Corporate Update for Half-Year Ending June 30, 2025
GlobeNewswire
·
July 30, 2025
Between December 2024 and July 2025, Oryzon secured financing totaling €52 M, approx. $61 M (€30.0 M from a capital increase, €7.0 M from commercial bank loans, €13.2 M from the EU-IPCEI grant, and €1.8 M from R…
US Signal Empowers Enterprises with New Infrastructure-as-a-Service Platform Leveraging the Industry Acclaimed InfiniBox™ SSA G4 Storage Solution
GlobeNewswire
·
July 30, 2025
WALTHAM, Mass., July 30, 2025 (GLOBE NEWSWIRE) -- Infinidat, a leading provider of enterprise storage solutions, today announced that US Signal Company, LLC (US Signal), a leading digital infrastructure provider and portfolio company of Igneo …
American Tungsten Announces Strategic Advancements in IMA Mine Rehabilitation and Exploration Program
GlobeNewswire
·
July 30, 2025
Vancouver, BC, July 30, 2025 (GLOBE NEWSWIRE) -- American Tungsten Corp. (CSE:TUNG) (OTCQB:DEMRF) (FSE:RK9) (“American Tungsten” or the “Company”) is pleased to provide a corporate update on its ongoing efforts to rehabilitate the historic IMA Mine in …
8th Presale Stage of Ethereum-Based Meme Coin Little Pepe (LILPEPE) Sells Out
GlobeNewswire
·
July 30, 2025
DUBAI, United Arab Emirates, July 30, 2025 (GLOBE NEWSWIRE) -- Momentum is real when the numbers do the talking. And right now, Little Pepe is speaking loud and clear. The Ethereum-based meme coin is officially wrapping up Stage 8 of its presale, selling …
Enlight Expands Its Executive Leadership Team
GlobeNewswire
·
July 30, 2025
Gilad Yavetz, founder of Enlight, to serve as Executive chairman of the board Adi Leviatan to be appointed CEO, bringing a proven track record of executive leadership from leading global companies; Yair Seroussi to serve as vice chairman This step, …
Nexxen to Announce Second Quarter 2025 Financial Results on August 13, 2025
GlobeNewswire
·
July 30, 2025
NEW YORK, July 30, 2025 (GLOBE NEWSWIRE) -- Nexxen International Ltd. (NASDAQ: NEXN) (“Nexxen” or the “Company”), a global, flexible advertising technology platform with deep expertise in data and advanced TV, will release its financial results for the …
Sensei Biotherapeutics to Present Clinical Data from the Phase 1 Dose Expansion Cohort of Solnerstotug at the ESMO Congress 2025
GlobeNewswire
·
July 30, 2025
BOSTON, July 30, 2025 (GLOBE NEWSWIRE) -- Sensei Biotherapeutics, Inc. (NASDAQ: SNSE), a clinical stage immuno-oncology company focused on the discovery and development of next generation therapeutics for cancer patients, announced today that clinical data …
Amerigo Announces Q2-2025 Results & Quarterly Dividend
GlobeNewswire
·
July 30, 2025
Q2-2025 Net Income of $7.5 million Robust EBITDA1 of $17.8 million and Free Cash Flow to Equity1 of $6.5 million 16th Consecutive Quarterly Dividend of Cdn$0.03 Declared $7.6 million Returned through Dividends and Share Buybacks in Q2-2025 VANCOUVER, …
Pancreatic Cancer Phase 2a Study with Can-Fite’s Namodenoson Achieved Over 50% Enrollment Milestone
GlobeNewswire
·
July 30, 2025
Primary endpoint is safety; Namodenoson continues to demonstrate a favorable safety profile Ramat Gan, Israel, July 30, 2025 (GLOBE NEWSWIRE) -- Can-Fite BioPharma Ltd. (NYSE American: CANF) (TASE: CANF), a clinical-stage biotechnology company developing a …